“…Despite favorable results [14][15][16], autologous tissues have some limitations to replace the absent conjunctiva or modulate the healing process, including unavailability of healthy conjunctiva in autoimmune diseases, cosmetic issues, and absence of goblets [7]. Therefore, allografts such as pericardium [10] and amniotic membrane (AM) have been introduced.…”